One of our biotech company supporters, argenx, is seeking participants for an advisory board to be held concurrent with the MGFA National Conference in Atlanta. The advisory board meeting will take place on March 30, 2019 from 2-5 pm.

argenx (www.argenx.com) is a biotechnology company that is conducting multiple clinical trials for severe autoimmune diseases, including MG. argenx is convening a group of patients to gain insights on the experiences of living with gMG. Your insights will inform product development and assist the company in identifying patient educational needs and gaps in available resources.

Specifically, argenx is looking for participants who meet the following criteria:

• Be 18 years of age or older
• Have a confirmed diagnosis of gMG
• Receiving IVIG at a regular interval
• Not be a current (or past) participant in any argenx clinical trial
• Live in the US
• Willing to share their experience of living with gMG

 

If you are interested in learning more about participation in this advisory board, please contact argenx’s agency partner, The Px Group, at PMassicotte@thepxgroup.com. The Px Group will reach out to determine your eligibility and discuss next steps.

All discussions, including the follow-up conversations, screening process and the advisory board itself, will be kept confidential. All personal and/or identifiable information will be maintained in confidence and will not be disclosed outside of argenx or used in any external presentations or communications.